| 2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
| 2924.21.04 | 00 | 3-(p-Chlorophenyl)-1,1-dimethylurea (Monuron) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-¡é/tolyl)urea (Fluometuron) | kg | Free | | 15.4¡é/kg + 40.5% |
| 2924.21.12 | 00 | 1-(2-Methylcyclohexyl)-3-phenylurea | kg | Free | | 15.4¡é/kg + 48.5% |
| 2924.21.18 | 00 | sym-Diethyldiphenylurea | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.3% (SG) | 15.4¡é/kg + 58% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-¡é/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 39.5% |
| 2925.11.00 | 00 | Imides and their derivatives; salts thereof: | | | | |
| 2925.21.00 | 00 | Imines and their derivatives; salts thereof: | | | | |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.30.10 | 00 | Fenproporex (INN) and its salts | kg | Free | | 15.4¡é/kg + 65.5% |
| 2929.10.15 | 00 | Mixtures of 2,4- and 2,6-toluenediisocyanates | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 2.9% (SG) | 15.4¡é/kg + 43.5% |
| 2930.90.26 | 00 | 3-(4'-Aminobenzamido)phenyl-¡é/hydroxy- ethylsulfone; 2-[(4-Aminophenyl)sulfonyl]ethanol, hydrogen sulfate ester; Diphenylthiourea; N,N'-(Dithiodi-2,1-phenylene)bisbenzamide; Pentachlorothiophenol; and 4,4'-Thiodiphenyl cyanate | kg | Free | | 15.4¡é/kg + 40.5% |
| 2930.90.71 | 00 | Dibutylthiourea | kg | Free | | 25% |
| 2931.00.70 | 00 | N,N'-Bis(trimethylsilyl)urea; 3-(Hydroxymethylphosphinyl)-1-propanoic acid, 2-hydroxyethyl ester; and 2-Phosphonobutane-1,2,4-tricarboxylic acid and its salts | kg | Free | | 25% |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4¡é/kg + 52% |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¡é/kg + 149.5% |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.52 | | Malonylurea (Barbituric acid) and its salts: | | | | |
